These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33924556)

  • 1. Oncolytic Virotherapy for Cancer: Clinical Experience.
    Chaurasiya S; Fong Y; Warner SG
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic virus therapy for prostate cancer.
    Fukuhara H; Homma Y; Todo T
    Int J Urol; 2010 Jan; 17(1):20-30. PubMed ID: 19832925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.
    Taguchi S; Fukuhara H; Todo T
    Jpn J Clin Oncol; 2019 Mar; 49(3):201-209. PubMed ID: 30462296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus, Oncolytic Virus and Human Prostate Cancer.
    Liu GB; Zhao L; Zhang L; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Poxviruses.
    Chan WM; McFadden G
    Annu Rev Virol; 2014 Sep; 1(1):119-141. PubMed ID: 25839047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poxvirus oncolytic virotherapy.
    Torres-Domínguez LE; McFadden G
    Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic virus therapy: A new era of cancer treatment at dawn.
    Fukuhara H; Ino Y; Todo T
    Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising oncolytic agents for metastatic breast cancer treatment.
    Cody JJ; Hurst DR
    Oncolytic Virother; 2015; 4():63-73. PubMed ID: 27512671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic viruses: From bench to bedside with a focus on safety.
    Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
    Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Viruses for Multiple Myeloma Therapy.
    Calton CM; Kelly KR; Anwer F; Carew JS; Nawrocki ST
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29903988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.
    Ji Q; Wu Y; Albers A; Fang M; Qian X
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of oncolytic virus therapy against cancer.
    Russell L; Peng KW
    Chin Clin Oncol; 2018 Apr; 7(2):16. PubMed ID: 29764161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.
    Masemann D; Boergeling Y; Ludwig S
    Biol Chem; 2017 Jul; 398(8):891-909. PubMed ID: 28441138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
    Breitbach CJ; Thorne SH; Bell JC; Kirn DH
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.